Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.10
-0.22 (-1.54%)
Mar 9, 2026, 1:57 PM EDT - Market open
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $1.87 billion as of March 9, 2026. Its market cap has increased by 67.24% in one year.
Market Cap
1.87B
Enterprise Value
1.56B
1-Year Change
67.24%
Ranking
Category
Stock Price
$14.10
Market Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $1.87B, an increase of 1,393.94%. That is a compound annual growth rate of 26.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.90B | -9.45% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ultragenyx Pharmaceutical | 2.05B |
| Soleno Therapeutics | 2.05B |
| Stoke Therapeutics | 2.03B |
| Nektar Therapeutics | 1.98B |
| Celldex Therapeutics | 1.96B |
| Syndax Pharmaceuticals | 1.95B |
| Tyra Biosciences | 1.89B |
| Recursion Pharmaceuticals | 1.83B |